Pharmaceutical Statistics

Cover image for Vol. 16 Issue 1

Edited By: David Morgan, Thomas Permutt and Jorgen Seldrup

Impact Factor: 1.235

ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 209/255 (Pharmacology & Pharmacy)

Online ISSN: 1539-1612

Recently Published Issues

See all


Estimands Special Issue

Welcome to the new Editor-in-Chief

We are delighted to welcome Jorgen Seldrup as one of three Editors-in-Chief of Pharmaceutical Statistics.

Jorgen Seldrup

As a seasoned Statistician, Jorgen has gained much experience since obtaining his postgraduate degree in Statistics from Aarhus University, Denmark, in 1971. His career started in January 1970 as the first statistician at Geigy UK Ltd, followed by five years with a Paris-based CRO prior to joining Quintiles in 1994.
He has also worked in Singapore as Director of the Clinical Trials & Epidemiology Research Unit (CTERU), Ministry of Health, and was responsible for creating disease registry, and was a member of the National Medical Research Council, Adjunct Associate Professor at the National University of Singapore, and an External Examiner, University of Hong Kong.
He returned to Quintiles in 2003 and joined the Centre for Statistics in Drug Development in 2006. He retired in mid-2012 and set up his own statistical consulting company, jStatConsult.
He is an honorary member of PSI (Statisticians in the Pharmaceutical Industry which he founded in 1977 and became its first chairman) and ISCB (International Society for Clinical Biostatistics of which he was President 1992-94).

Recently Published Articles

  1. Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practice

    Sheila M. Bird, Rosemary A. Bailey, Andrew P. Grieve and Stephen Senn

    Version of Record online: 16 FEB 2017 | DOI: 10.1002/pst.1801

  2. Robust inference for group sequential trials

    Jitendra Ganju, Yunzhi Lin and Kefei Zhou

    Version of Record online: 30 JAN 2017 | DOI: 10.1002/pst.1800

  3. A simulation study of methods for selecting subgroup-specific doses in phase 1 trials

    Satoshi Morita, Peter F. Thall and Kentaro Takeda

    Version of Record online: 23 JAN 2017 | DOI: 10.1002/pst.1797

  4. You have full text access to this OnlineOpen article